1. Home
  2. RCUS vs ANDE Comparison

RCUS vs ANDE Comparison

Compare RCUS & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • ANDE
  • Stock Information
  • Founded
  • RCUS 2015
  • ANDE 1947
  • Country
  • RCUS United States
  • ANDE United States
  • Employees
  • RCUS N/A
  • ANDE N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • ANDE Farming/Seeds/Milling
  • Sector
  • RCUS Health Care
  • ANDE Industrials
  • Exchange
  • RCUS Nasdaq
  • ANDE Nasdaq
  • Market Cap
  • RCUS 1.2B
  • ANDE 1.3B
  • IPO Year
  • RCUS 2018
  • ANDE N/A
  • Fundamental
  • Price
  • RCUS $12.03
  • ANDE $39.46
  • Analyst Decision
  • RCUS Buy
  • ANDE Buy
  • Analyst Count
  • RCUS 8
  • ANDE 3
  • Target Price
  • RCUS $20.71
  • ANDE $51.67
  • AVG Volume (30 Days)
  • RCUS 711.9K
  • ANDE 277.1K
  • Earning Date
  • RCUS 11-05-2025
  • ANDE 11-03-2025
  • Dividend Yield
  • RCUS N/A
  • ANDE 1.97%
  • EPS Growth
  • RCUS N/A
  • ANDE N/A
  • EPS
  • RCUS N/A
  • ANDE 2.35
  • Revenue
  • RCUS $262,000,000.00
  • ANDE $11,539,093,000.00
  • Revenue This Year
  • RCUS N/A
  • ANDE $9.10
  • Revenue Next Year
  • RCUS N/A
  • ANDE $2.78
  • P/E Ratio
  • RCUS N/A
  • ANDE $16.85
  • Revenue Growth
  • RCUS 6.07
  • ANDE N/A
  • 52 Week Low
  • RCUS $6.50
  • ANDE $31.03
  • 52 Week High
  • RCUS $18.98
  • ANDE $51.58
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 66.27
  • ANDE 49.25
  • Support Level
  • RCUS $11.30
  • ANDE $38.33
  • Resistance Level
  • RCUS $12.05
  • ANDE $40.98
  • Average True Range (ATR)
  • RCUS 0.58
  • ANDE 1.05
  • MACD
  • RCUS 0.02
  • ANDE -0.28
  • Stochastic Oscillator
  • RCUS 81.30
  • ANDE 28.04

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

Share on Social Networks: